Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-25-009904
Filing Date
2025-05-20
Accepted
2025-05-20 19:46:28
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 3534
  Complete submission text file 0001062993-25-009904.txt   5140
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102
Business Address
PISKEL KYLE (Reporting) CIK: 0001780662 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38957 | Film No.: 25970571